Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 59.10
+0.15 (0.25%)
Dec 5, 2025, 4:09 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 17.41 billion as of December 5, 2025. Its market cap has increased by 56.37% in one year.
Market Cap
17.41B
Enterprise Value
15.30B
Revenue
955.73M
Ranking
n/a
PE Ratio
n/a
Stock Price
59.10
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has decreased from 18.43B to 17.41B, a decrease of -5.52%. That is a compound annual growth rate of -1.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 17.41B | 104.45% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 284.43B |
| Hansoh Pharmaceutical Group Company | 243.25B |
| JD Health International | 192.25B |
| Innovent Biologics | 157.33B |
| WuXi Biologics | 126.66B |
| Sino Biopharmaceutical | 120.67B |
| Akeso | 108.88B |
| Sichuan Kelun-Biotech Biopharmaceutical | 100.74B |